Stanford University scientists have found that erythropoietin (EPO), a protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells also plays a surprising ...

Erythropoietin (Epo) exhibits properties that may attenuate this process and enhance neovascularization, thereby preserving jeopardized myocardium. Potentially adverse effects of Epo, ...

Erythropoietin (EPO), a glycoprotein hormone, is a fundamental regulator of erythropoiesis. The expression of EPO is tightly regulated by local changes in the partial pressure of oxygen.

Erythropoietin, aka EPO, is best known for its role in the Lance Armstrong cheating scandal. But EPO is also the star of another, darker tale.

The Erythropoietin (EPO) drugs market is a vital segment of the pharmaceutical industry that focuses on the development and distribution of medications aimed at stimulating red blood cell production.

The global erythropoietin drugs market was valued at approximately USD 6.87 billion in 2022 and is projected to grow at a healthy growth rate of around 1.5% during the forecast period from 2023 to ...

Low plasma erythropoietin (EPO) levels are a major factor in anemia of prematurity. Erythroid progenitors from neonates have responded well to EPO in vitro, (studies performed outside a living ...

First market approval for Genexine discovered and developed therapeutic drug, Efesa (Efepoetin alfa), a long-acting erythropoietin (EPO) for the treatment of Chronic Kidney disease Induced anemia ...

Erythropoietin (EPO) is a 30.4 kDa glycoprotein comprised of one 165 amino acid residues chain with four glycosylation locations (Figure 1). The hormone is produced naturally in the kidneys ...

An Australian-born Irish professional cyclist, Jesse Ewart, has been banned from cycling for three years after he tested positive for EPO (Erythropoietin) this year. Ewart, who rode for the ...